Medical travelers and public health officials visited Hawaii specifically to observe and learn from the program’s approach. The Hawaiian program had a relatively high profile in the international leprosy medicine community during this period — partly because of the scale of the Kalaupapa settlement (which made it one of the larger populations of leprosy patients under medical observation anywhere in the world), partly because of the documented outcomes with the injectable preparation, and partly because Hawaii’s status as a U.S. territory with significant federal public health investment meant that the program had resources that comparable programs elsewhere lacked.

 

Hollmann’s 1922 paper was part of this international conversation. It appeared in a medical journal read by physicians working on leprosy in multiple countries and was explicitly addressing a question — which preparation to use and how — that practitioners internationally were trying to answer. The specific attribution of the method to Ball was embedded in a clinical paper that was primarily about treatment outcomes; readers came to it for the clinical data and may have absorbed the attribution as a secondary detail.

 

The international spread of the injectable chaulmoogra method in the 1920s meant that Ball’s contribution — without her name — was diffusing through global medical practice. Patients in India, in the Philippines, in various African countries, in Brazil, and elsewhere were being treated with variations of the injectable preparation that Ball had developed, by physicians who had learned the method from papers that did not credit her. The scale of this diffusion is difficult to quantify but was substantial.

ADVERTISEMENT
Advertisement
Share.